Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach

Published:2023-12-07 Issue:1 Volume:39 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Li Keting¹,Hu Wenshu¹,Wang Yingjie¹,Chen Wenxing¹,Wen Hongmei¹,Liu Jian¹,Li Wei¹,Wang Bo¹^ORCID

Affiliation:

1. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China

Funder

National Science Foundation of China

Jiangsu Specially-Appointed Professors program

Research Foundation of the Nanjing University of Chinese Medicine

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2023.2288810

Reference29 articles.

1. The p53 family in differentiation and tumorigenesis;Stiewe T.;Nat Rev Cancer,2007

2. Regulating the P53 pathway: in vitro hypotheses, in vivo veritas;Toledo F;Nat Rev Cancer,2006

3. Live or let die: the cell’s response to P53;Vousden KH;Nat Rev Cancer,2002

4. P53 signaling in cancer progression and therapy;Marei HE;Cancer Cell Int,2021

5. MDM2, MDMX and P53 in oncogenesis and cancer therapy;Wade M;Nat Rev Cancer,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular, Structural Basis, and Recent Progress for Targeting Murine Double Minute X (MDMX) in Tumors;Journal of Medicinal Chemistry;2024-08-26

2. Perspectives on current approaches to virtual screening in drug discovery;Expert Opinion on Drug Discovery;2024-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3